Back
NFM
New Frontier Minerals Limited
π¦πΊ ASX
βοΈ MINING
π Overview
π Performance
π΅ Cost
π€ Advanced
π¨βπ©βπ§βπ¦ Community
π
-12.56%
Annual Growth
5 years average annual capital growth
π΅
$ 500
Minimum Order
Due to regulatory requirements
π
7
Pearlers Invested
Since January 2020
π Overview
Key information
π Fund Overview
New Frontier Minerals Ltd. engages in the business of mineral exploration and examination of new resource opportunities which focuses on copper, cobalt, and rare earth elements projects in Australia and Zambia. The company is headquartered in Perth, Western Australia. The company went IPO on 2010-12-14. Its projects include the Harts Range Project and the NWQ Copper Project. The Harts Range Project comprises two granted tenements and an application license for a total of 135 square kilometers (km2), approximately 140 kilometers (km) north-east of Alice Springs, with mining infrastructure and access to a skilled labor pool. The Harts Range Project is situated northwest of the Entia Dome and lies within the Harts Range Group. The NWQ Copper Project comprises five mineral leases, covering a total area of 977 km2. The NWQ Copper Project is located approximately 150 km north of Mt Isa in Queensland, and hosts several historic / operating copper mines, including Lady Annie, Mt Oxide and Capricorn Copper. Its additional project, Mkushi Project, is located within the Mwembeshi Shear Zone (MSZ).
π Performance
Price History
+700.00%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
ποΈ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out βπ΅ Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out ββ±οΈ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out βπ΅ Costs
πΌ
N/A
Management Fee
Included in unit price, not charged by Pearler
πΈ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πΈ Net fee calculatorπ€ Advanced information
Technical Info
π° Price*
$0.02
*Price may be up to 24 hours old
π©βπ©βπ¦ Community Insights
How our community is investing
π Pearlers invested in NFM
7
π Total Capital Earnings
$8K
π Average investment frequency
27 weeks
π΅ Average investment amount
$1,312
β° Last time a customer invested in NFM
14 hours
NFM investor breakdown
π΅ Income of investors
More than 200k
150k - 200k
25%
100k - 150k
50%
50k - 100k
Less than 50k
25%
πΆ Age of investors
18 - 25
14%
26 - 34
43%
35 - 90
43%
π Legal gender of investors
Female
57%
Male
43%
Pearlers who invest in NFM also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
π Performance (5Yr p.a)
9.37%
π Share price
$111.56 AUD
π¦πΊ AUSTRALIA
πΈ FINANCIALS
π§± MATERIALS
β³οΈ DIVERSIFIED
π HIGH PRICE GROWTH
Commonwealth Bank of Australia engages in the provision of banking and financial services. The company is headquartered in Sydney, New South Wales and currently employs 51,346 full-time employees. Its segments include Retail Banking Services, Business Banking, Institutional Banking and Markets, New Zealand, and Corporate Center and Other. Retail Banking Services provides banking products and services to personal and private bank customers, helping them to manage their everyday banking needs, buy a home or invest in the future. Business Banking serves the banking needs of business, corporate and agribusiness customers across the full range of financial services solutions. The company also provides equities trading and margin lending services through the CommSec business. Institutional Banking and Markets offers a full range of domestic and global financing and banking services to institutional and government clients. New Zealand includes the banking and funds management businesses operating in New Zealand under the ASB brand.
π Performance (5Yr p.a)
31.51%
π Share price
$170.38 AUD
π HIGH PRICE GROWTH
π¦ BANKING
Wesfarmers Ltd. engages in the provision of fresh food, groceries, general merchandise, liquor, fuel, and financial services. The company is headquartered in Perth, Western Australia and currently employs 118,000 full-time employees. Its Kmart segment is a retailer of apparel and general merchandise, including toys, leisure, entertainment, home and consumables. Its Energy and Fertilizers (WesCEF) segment is a manufacturer and marketer of chemicals for industry, mining and mineral processing. Its Officeworks segment is a retailer and supplier of office products and solutions for households and small-to-medium-sized businesses. Its Industrial and Safety segment is a supplier and distributor of maintenance, repair and operating products. Its Wesfarmers Health (Health) segment is a wholesaler and retailer of pharmaceutical goods, health, wellness and beauty products. Its Catch segment is an online retailer offering branded products on a first-party basis and a third-party online marketplace. Its Other segments include OneDigital, Forest products, and Property.
π Performance (5Yr p.a)
22.15%
π Share price
$91.55 AUD
π HIGH PRICE GROWTH
ποΈ CONSUMER
PYC Therapeutics Ltd. is a drug-development company, which provides a new generation of RNA therapeutics to meet unmet need in disease. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2005-03-30. The firm utilizes its proprietary drug delivery platform to enhance the potency of precision medicines within the rapidly growing and commercially proven RNA therapeutic class. Its drug development programs target monogenic diseases - the indications with the highest likelihood of success in clinical development. Its first-in-class drug programs include Retinitis Pigmentosa type 11, (VP-001), Polycystic Kidney Disease, (PYC-003), Autosomal Dominant Optic Atrophy (ADOA) (PYC-001) and Phelan-McDermid Syndrome (PMS) (PYC-002). The firm's VP-001 program is a lead asset for a blinding eye disease of childhood progressed through multiple patient cohorts in the ongoing single ascending dose clinical trial. ADOA is a progressive and blinding eye disease.
π Performance (5Yr p.a)
123.56%
π Share price
$1.14 AUD
𧬠BIOTECHNOLOGY
IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
π Performance (5Yr p.a)
23.02%
π Share price
$67.97 AUD
π HIGH PRICE GROWTH
πΊπΈ UNITED STATES
Want more shares? Try these...
π Performance (5Yr p.a)
2.02%
π Share price
$89.20 AUD
π° HIGH DIVIDEND